Concepedia
Statistics
Publications
1
Citations
21
H-Index
Active since
2024
Affiliations
Inserm(Current)
Imène Tabet is an author at Inserm specializing in cdk inhibitors, olaparib therapy, and in vivo resistance assays.
Publications per year
2024–2024
CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer
Esin Orhan, Carolina Velázquez, Imène Tabet et al. · Cancer Letters · 2024 · 21 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1